Blog

September 11, 2025September 11, 2025

The Vision Council Releases New Report on Myopia Treatment Trends

The Vision Council has released a new two-part research report, Focused inSights 2025: Myopia Management, offering a combined global and U.S. perspective on pediatric myopia treatment. The dual-format report compares regulatory and product availability trends internationally with survey data from U.S. eyecare providers, creating one of the most comprehensive views of current approaches to childhood myopia care.

Comparative Myopia Treatment Strategies

The first section examines treatment availability across the U.S., Canada, the U.K., and the EU, with a focus on four major categories: low-dose atropine drops, myopia control spectacle lenses, multifocal or dual-focus daily soft contact lenses, and orthokeratology.

The report highlights uneven adoption across markets, noting milestones such as the EU’s approval of Ryjunea atropine drops and France’s decision to fully reimburse myopia control spectacle lenses. It also considers financing models and prescribing practices across different regions.

Provider Approaches in the U.S.

The second section presents findings from a survey of 293 U.S. optometrists, practice owners, and managers conducted between June 16 and July 4, 2025. Key insights include:

Proactive screening: 91% of providers recommend myopia screenings at least once a year.
Treatment adoption: About 70% of providers report offering myopia management to children in their practice.
Most common treatment: MiSight® contact lenses are prescribed most frequently (81%).
Motivations: Providers cite slowing progression (78%), reducing complication risks (78%), and improving long-term eye health (71%) as leading reasons to treat.
Risk factors: Excessive screen time (82%), genetics (82%), and limited outdoor activity (77%) were identified as the main drivers of myopia.
Challenges: Cost (86%), parental understanding (56%), and patient compliance (49%) remain significant barriers.

“This dual-format report provides both a global and a local lens on myopia management,” said Alysse Henkel, Vice President of Research and inSights at The Vision Council. “It’s clear that U.S. providers take myopia seriously, but they also face challenges in affordability and patient education. By including an international analysis, we can see where care stands today and where it is headed.”

The full report is available through The Vision Council’s Research Download Center. Members may access the report at no cost; non-members can purchase it for $5,000.

Source: The Vision Council

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

September 11, 2025September 11, 2025

Neurolens Rebrands as Newton, Signaling Next Phase of Optical Innovation

Neurolens, known for developing Contoured Prism™ technology to address binocular vision issues, has officially rebranded as Newton™. The company says the change reflects a strategic evolution and renewed focus on innovation in eye care.

The new name pays homage to Sir Isaac Newton, widely regarded as one of history’s most influential scientists in mathematics, physics, astronomy, and optics. Company leaders say this spirit of discovery aligns with Newton’s mission to challenge conventional standards in optometry and uncover new possibilities in vision care.

From Neurolens to Newton

Neurolens launched over a decade ago following research into how binocular vision impacts the trigeminal nerve, particularly during near vision tasks. Its Contoured Prism technology was designed to help eyes work together more comfortably, alleviating symptoms such as headaches, neck pain, and eye strain.

Clinical studies show that approximately 90% of patients report relief from symptoms related to eye misalignment after wearing Neurolenses. The company has since expanded beyond neurology clinics to serve hundreds of thousands of patients across North America.

A New Era of Innovation

As Newton, the company says it will continue supporting optometry practices while introducing new technologies later this month. “Newton represents more than a rebrand—it signals the next chapter in transforming eye care beyond 20/20,” said Davis Corley, CEO. “We don’t just meet expectations—we set new ones.”

Dr. Evie Lawson, an optometrist in Seattle who prescribes Neurolenses, said the technology has been “practice-changing” for her and life-changing for patients. “Newton represents the next level of innovation in eye care, consistently supporting optometry to deliver optimized patient experiences,” Lawson said.

The rebrand positions Newton as an innovation company focused on redefining eye care through patient-centered outcomes and advanced technologies.

Full announcement: Neurolens Rebrands as Newton – PR Newswire

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

September 11, 2025September 11, 2025

Study Finds XIIDRA May Improve Comfort for Symptomatic Contact Lens Wearers

Results from a new investigator-initiated study suggest that XIIDRA® (lifitegrast ophthalmic solution 5%), a prescription drop approved for dry eye disease, may help reduce end-of-day eye dryness and discomfort among symptomatic contact lens wearers.

The study, conducted at the Centre for Ocular Research & Education (CORE) at the University of Waterloo and published in Clinical Ophthalmology, followed 40 participants over 12 weeks. Participants continued wearing their usual contact lenses while using XIIDRA twice daily.

Key Findings

Significant improvement in symptoms: After 12 weeks, median scores for end-of-daydryness and discomfort improved by 61 and 59 points, respectively, on a 100-point scale.
Early response: Nearly half of participants reported reduced symptoms after just two weeks of treatment, to the extent they would no longer have met study eligibility.
Longer wear time: Comfortable lens wear increased by an average of 2.6 hours (from 6.5 to 9.1 hours), though total wear time did not change.
Broad symptom relief: Improvements were noted in burning/stinging, itching, foreign body sensation, light sensitivity, and pain.
Safety profile: XIIDRA was generally well tolerated, with only two reports of treatment-related adverse events.

Dr. Marc-Matthias Schulze, principal investigator and senior clinical scientist at CORE, noted that improvements were evident as early as two weeks and continued throughout the study. “Results showed that continued use of XIIDRA further improved symptoms, demonstrating that it may allow contact lens wearers to enjoy their lenses throughout the entire day,” he said.

Study Limitations

The study was single-center, open-label, and lacked a control group. Investigators caution that frequent use of prescription drops compared with occasional use of over-the-counter rewetting drops may have contributed to symptom improvements. As such, findings should be interpreted within the limits of the study design, and no formal conclusions can be drawn.

Background

XIIDRA is approved for the treatment of signs and symptoms of dry eye disease. While over-the-counter rewetting drops often provide only temporary relief for contact lens wearers, this study indicates that XIIDRA may represent an alternative option for those with persistent discomfort.

Source: Bausch + Lomb

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

September 11, 2025September 11, 2025

SILMO Paris 2025: Tech Village Launch Highlights AI and Smart Eyewear

Silmo 2025 THE PLACE TO BE, TO SEE, TO FORESEE

At SILMO Paris 2025, the spotlight will be on the future of optics with the debut of the Tech Village, a new space dedicated entirely to artificial intelligence and smart eyewear.

Building on the success of SILMO Next, the Tech Village is designed as a meeting point between research, technology, and professional practice.

A Forward-looking Program

20 exhibitors including: EssilorLuxottica, ACEP, Chamelo, Lucyd Audio Eyewear, Solos.
Exclusive experiences from: Everysight, GETD, Laclarée, My Vision Show, Skugga, Titan, VRAI Learning, Widid.
Workshops and talks hosted by: Snapchat, Meta, Google.

A Laboratory of Ideas and Trends

With the launch of the Tech Village, SILMO Paris reinforces its position as a laboratory of innovation, where today’s experiments shape tomorrow’s optical industry.

Source : SILMO Paris

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

September 10, 2025September 11, 2025

Oakley® and Justin Jefferson Unveil his First Signature Series

The Justin Jefferson Signature Series Oakley De Soto™ fuses standout design and innovation to reflect his style, energy, and influence beyond the game.

Oakley® and Justin Jefferson debut the Justin Jefferson Signature Series Oakley De Soto™, his first with the brand. Inspired by his own personal style, the eyewear embodies Jefferson’s distinct blend of athletic dominance and bold personal expression, on and off the field. This statement silhouette is all about the details, with premium design elements inspired directly by one of football’s most dynamic young talents.

2025_NA_Football_JJ_Sig_Series_De_Soto_JustinJefferson

Part of the Player’s Collection, De Soto is a true blend of style and thoughtful, refined design. Channeling the retro energy of 1960s acetate eyewear and fueled by signature Oakley technology, the ending result is a bold dual‑lens profile, made to stand out.

Infused with Oakley DNA, lightweight, durable O Matter™ delivers all-day comfort and rugged resilience, while Prizm™ Lens Technology amps color and contrast. The high-bridge, full-rim rectangular frame is finished in a deep purple gradient with platinum accents. Reflecting Jefferson’s captivating aesthetic, the temples are adorned with diamond-encrusted Oakley Fractal logos. As a final, personal touch, the product is delivered in custom premium packaging featuring the athlete’s signature jet motif.

“It’s surreal to see my own Signature Series with Oakley come to life — from wanting a partnership to building those connections and now holding the product in my hands. It shows that the work I put in on the field, and the person I strive to be off the field, truly pays off,” Justin Jefferson, Oakley athlete and All-Pro Minnesota Vikings Wide Receiver. “I’m incredibly thankful for this opportunity and grateful to my parents for shaping me into who I am today.”

The Justin Jefferson Signature Series Oakley De Soto™ is available on Oakley.com beginning September 9th, followed by an in-store release at Oakley retail locations. For more information on Oakley’s football and lifestyle collections, and Team Oakley, please visit Oakley.com.